Podcast: Non-binding Guidance: SEC Disclosure Issues for Life Sciences Companies
In response to the rapidly evolving landscape of innovation and the integration of artificial intelligence (AI) into creative processes, the United States Patent and Trademark Office (USPTO) issued guidance effective February...more